News
Oncologists Urged to Have Open Discussion about CAM Use with Patients
CAM use linked to higher mortality in breast cancer patients A cohort study of women with breast cancer has shown that use of complementary and alternative medicine (CAM) in association with traditional therapies was associated with higher mortality compared with…
The Scientists Who Turned Cancer Prevention into a Vaccine: Dr Douglas Lowy and Dr John Schiller
The 2026 Pezcoller Foundation–AACR International Award for Extraordinary Achievement in Cancer Research has recognised two scientists whose discoveries reshaped one of oncology’s greatest ambitions: preventing cancer before it begins. On 9 May, at the Teatro Sociale in Trento, Italy, Dr…
Cancer is Universal. Meaning is Not!
She nodded when I said cancer. Only later did I understand that she had heard something else. The consultation unfolded with clinical precision. The translation was accurate. From a professional perspective, nothing was missing. And yet everything was. When I…
CancerWorld #116 (June 2026)
We tend to talk about cancer in the language of progress—new therapies, wider prevention, smarter models of care. It is a comforting vocabulary. It is also incomplete. Progress in oncology is never only scientific. It is institutional, social, and deeply…
A Survivor’s Perspective: San Diego’s Rise as a National Cancer Research Hub
How policy, philanthropy, and scientific collaboration are reshaping the cancer research landscape and why early detection can be the difference between life and death. Twenty years ago, I received a diagnosis that changed everything and led me to dedicate the…
A Matter of Timing: Radiotherapy Efficacy Linked to Circadian Regulation
Timing of radiotherapy administration may significantly influence treatment efficacy in breast and prostate cancer. A Spanish study, published in Nature Communications, demonstrates that circadian oscillation of Cryptochrome 1 (CRY1) modulates DNA double-strand break (DSB) repair, making radiotherapy more effective in…
CancerWorld #115 (May 2026)
In oncology, progress is measured in survival rates, response curves, and treatment gains. But those numbers rest on a quieter assumption: that health systems can deliver what science makes possible. When they cannot, progress becomes uneven—not in discovery, but in…
Cancer Vaccines: From Missed Promise to Second Chance
In oncology, some ideas arrive too early. For decades, cancer vaccines were one of them. The concept was elegant: train the immune system to recognise tumour cells, much like it recognises viruses, and allow it to eliminate disease with precision…
CancerWorld | The Max Foundation – Special Issue 2026
25 Years of TKIs in CML: A Revolution and a Responsibility Twenty-five years ago, the arrival of imatinib changed the course of a disease and the lives of countless people diagnosed with it. Chronic myeloid leukemia (CML), once defined by…
CancerWorld #114 (April 2026)
In oncology, we are trained to deliver hope alongside difficult truths. We speak about survival rates, probabilities, and outcomes. In conflict settings, those terms lose stability. What does survival mean when hospitals are destroyed, treatments cannot reach patients, and people…